zidovudine has been researched along with Myelodysplastic Syndromes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullis, JE; Cronkite, EP; Hirabayashi, Y; Inoue, T; Mitsui, H; Umemura, T | 1 |
Biesma, DH | 1 |
1 review(s) available for zidovudine and Myelodysplastic Syndromes
Article | Year |
---|---|
Erythropoietin treatment for non-uremic patients: a personal view.
Topics: Anemia; Anti-HIV Agents; Arthritis, Rheumatoid; Blood Transfusion, Autologous; Chemotherapy, Adjuvant; Erythropoietin; Female; Humans; Male; Multiple Myeloma; Myelodysplastic Syndromes; Recombinant Proteins; Uremia; Zidovudine | 1999 |
1 other study(ies) available for zidovudine and Myelodysplastic Syndromes
Article | Year |
---|---|
Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
Topics: Acquired Immunodeficiency Syndrome; Anemia, Macrocytic; Animals; Anti-HIV Agents; Bone Marrow; Colony-Forming Units Assay; Erythrocyte Count; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hyperplasia; Male; Mice; Mice, Inbred CBA; Myelodysplastic Syndromes; Thrombocytopenia; Time Factors; Zidovudine | 1997 |